v3.24.1.1.u2
Shareholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Shareholders’ Equity [Abstract]  
Schedule of Company's RSU Award Activity A summary of the Company’s RSU award activity for the three months ended March 31, 2024 and 2023, respectively, is as follows:
   Restricted
Stock
Units
   Weighted
Average
Grant Date
Fair Value
 
Outstanding at December 31, 2023   2,185,210   $0.20 
Granted   
-
    
-
 
Vested   (1,004,982)   0.23 
Forfeited   (68,500)   .13 
Outstanding at March 31, 2024   1,111,728   $0.18 
   Restricted
Stock
Units
   Weighted
Average
Grant Date
Fair Value
 
Outstanding at December 31, 2022   1,453,857   $0.30 
Granted   2,760,660    0.17 
Vested   (1,877,932)   0.23 
Forfeited   
-
    
-
 
Outstanding at March 31, 2023   2,336,585   $0.21 
Schedule of Stock Option Activity A summary of the Company’s stock option activity for the three months ended March 31, 2024 and 2023, respectively, is as follows:
   Stock
Option
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2023   11,513,214   $0.17    7.3   $1,962,017 

Granted

   8,085,081    0.05    5.4    57,557 
Forfeited   
-
    
-
    
-
    
-
 
Outstanding at March 31, 2024   19,598,295   $0.12    6.4   $2,019,574 
   Stock
Option
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2022   8,500,000   $0.18    8.5   $1,579,108 

Granted

   
-
    
-
    
-
    
-
 
Forfeited   
-
    
-
    
-
    
-
 
Outstanding at March 31, 2023   8,500,000   $0.18    8.0   $1,579,108 
Schedule of Warrant Activity A summary of the Company’s warrant activity for the three months ended March 31, 2024 and 2023, respectively, is as follows:
   Warrant
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
   Aggregate
Fair
Value
 
Outstanding at December 31, 2023   51,662,689   $0.45    2.9   $2,817,424 
Granted   
-
    
-
    
-
    
-
 
Exercised   
-
    
-
    
-
    
-
 
Expired   
-
    
-
    
-
    
-
 
Outstanding at March 31, 2024   51,662,689   $0.45    2.7   $2,817,424 
   Warrant
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
   Aggregate
Fair
Value
 
Outstanding at December 31, 2022   73,950,000   $0.40    1.0   $1,867,754 
Granted   
-
    
-
    
-
    
-
 
Exercised   
-
    
-
    
-
    
-
 
Expired   (15,000,000)   
-
    
-
    
-
 
Outstanding at March 31, 2023   58,950,000   $0.40    0.9   $1,867,754